Currenc Group, Inc. (CURR)

USD 1.41

(-0.28%)

Long Term Debt Summary of Currenc Group, Inc.

  • Currenc Group, Inc.'s latest annual long term debt in 2023 was 2.5 Million USD , up 5349.94% from previous year.
  • Currenc Group, Inc.'s latest quarterly long term debt in 2024 Q2 was - USD , down -100.0% from previous quarter.
  • Currenc Group, Inc. reported annual long term debt of 46 Thousand USD in 2022, down -77.11% from previous year.
  • Currenc Group, Inc. reported annual long term debt of 201 Thousand USD in 2021, down -97.26% from previous year.
  • Currenc Group, Inc. reported quarterly long term debt of 2.86 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Currenc Group, Inc. reported quarterly long term debt of 2.5 Million USD for 2023 FY, up 5349.94% from previous quarter.

Annual Long Term Debt Chart of Currenc Group, Inc. (2023 - 2014)

Historical Annual Long Term Debt of Currenc Group, Inc. (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 2.5 Million USD 5349.94%
2022 46 Thousand USD -77.11%
2021 201 Thousand USD -97.26%
2020 7.32 Million USD 13992.31%
2019 52 Thousand USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD -100.0%
2015 9453.00 USD -99.6%
2014 2.38 Million USD 0.0%

Peer Long Term Debt Comparison of Currenc Group, Inc.

Name Long Term Debt Long Term Debt Difference
Theratechnologies Inc. 51.26 Million USD 95.109%
Safety Shot Inc 304.9 Thousand USD -722.209%
Biofrontera Inc. 804 Thousand USD -211.813%
DURECT Corporation 2.7 Million USD 7.218%
Cosmos Health Inc. 3.03 Million USD 17.407%
Cronos Group Inc. 1.55 Million USD -60.807%
Esperion Therapeutics, Inc. 501.54 Million USD 99.5%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 99.497%
Kala Pharmaceuticals, Inc. 34.19 Million USD 92.668%
RedHill Biopharma Ltd. 455 Thousand USD -450.983%
Organogenesis Holdings Inc. 60.74 Million USD 95.873%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD 75.561%
Sunshine Biopharma, Inc. 539.03 Thousand USD -365.086%
Alpha Teknova, Inc. 13.25 Million USD 81.081%
Intra-Cellular Therapies, Inc. 13.32 Million USD 81.187%
SCYNEXIS, Inc. 12.15 Million USD 79.382%
ANI Pharmaceuticals, Inc. 309.66 Million USD 99.19%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -2781.579%
Dynavax Technologies Corporation 252.41 Million USD 99.007%
Aquestive Therapeutics, Inc. 91.07 Million USD 97.247%
SIGA Technologies, Inc. 335.99 Thousand USD -646.143%
Lifecore Biomedical, Inc. 120.51 Million USD 97.92%
Shineco, Inc. 10.01 Million USD 74.974%
Indivior PLC 235.66 Million USD 98.936%
Regencell Bioscience Holdings Limited - USD -Infinity%
Radius Health, Inc. 339.66 Million USD 99.262%
Sunshine Biopharma, Inc. 539.03 Thousand USD -365.086%
Incannex Healthcare Limited 210 Thousand USD -1093.797%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -2040.353%
Alimera Sciences, Inc. 64.48 Million USD 96.113%
Silver Spike Investment Corp. - USD -Infinity%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -1755.794%
Alvotech 1.02 Billion USD 99.756%
Journey Medical Corporation 14.62 Million USD 82.855%
Petros Pharmaceuticals, Inc. 6.85 Million USD 63.441%
Embecta Corp. 1.62 Billion USD 99.846%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -11050.036%
Procaps Group, S.A. 28.41 Million USD 91.176%
PainReform Ltd. 30 Thousand USD -8256.58%
Harrow Health, Inc. 183.17 Million USD 98.631%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 92.448%
OptiNose, Inc. 611 Thousand USD -310.307%
Kamada Ltd. 7.43 Million USD 66.295%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 80.39%
Phibro Animal Health Corporation 458.28 Million USD 99.453%
Procaps Group S.A. 28.41 Million USD 91.176%
TherapeuticsMD, Inc. 6.53 Million USD 61.62%
Talphera, Inc. - USD -Infinity%
Viatris Inc. 16.18 Billion USD 99.985%
Rockwell Medical, Inc. 8.29 Million USD 69.77%
Aytu BioPharma, Inc. 10.87 Million USD 76.952%
Tilray Brands, Inc. 287.93 Million USD 99.129%
Collegium Pharmaceutical, Inc. 489.96 Million USD 99.488%
PetIQ, Inc. 437.82 Million USD 99.427%
Neurocrine Biosciences, Inc. 258.3 Million USD 99.029%
Assertio Holdings, Inc. 38.51 Million USD 93.491%
Lantheus Holdings, Inc. 616.12 Million USD 99.593%
Avadel Pharmaceuticals plc 32.75 Million USD 92.347%
Hempacco Co., Inc. 5.93 Million USD 57.731%
Pacira BioSciences, Inc. 513.79 Million USD 99.512%
Alvotech 1.02 Billion USD 99.756%
Evoke Pharma, Inc. 5 Million USD 49.861%
Flora Growth Corp. 942 Thousand USD -166.133%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -11050.036%
Evolus, Inc. 120.35 Million USD 97.917%
HUTCHMED (China) Limited 48.18 Million USD 94.798%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 99.575%
Akanda Corp. 2.49 Million USD -0.393%